Bank of Montreal
CLMT icon

Bank of Montreal’s Calumet Specialty Products CLMT Stock Holding History

Bank of Montreal’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-46,100
Closed -$622K – 4129
2022
Q1 		$622K Buy
+46,100
New +$679K ﹤0.01% 2676

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
BCM
Bienville Capital Management New York $550M AUM 3.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's CLMT Position: Q1 2022 in Review

Bank of Montreal sold out of Calumet Specialty Products (CLMT) in Q1 2022, closing a stake of 58,500 shares — an estimated $861K sold.

Bank of Montreal first reported a position in CLMT in Q2 2013 and held it in 18 quarters. The position peaked at $760K in Q4 2021. 61 funds tracked by Wall St. Rank hold CLMT as of Q1 2022.

  • Bank of Montreal reported no remaining Calumet Specialty Products position as of Q1 2022 after selling out during the quarter.
  • Bank of Montreal sold 58,500 Calumet Specialty Products shares in Q1 2022, an estimated $861K.
  • Bank of Montreal first reported a position in Calumet Specialty Products in Q2 2013 and held it in 18 quarters.
  • Bank of Montreal's Calumet Specialty Products position peaked at $760K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2022.

Based on Bank of Montreal's 13F filing for Q1 2022, filed 12 May 2022.